Originally published by Quantzig: Patient Journey Analysis Helped a Diabetes Drugs Manufacturer to Comprehend the Effectiveness of Clinical Trials Against Real-World Data
Highlights of the Case Study:
- About the Client: A leading diabetes drugs manufacturer
- Area of Engagement: Patient journey analysis
- Industry Overview: Insights into the dynamic diabetes drug market
- Pharma Patient Journey Challenge: Understanding patient journeys for diabetes diagnosis
- Solution Benefits: Real-world performance insights and clinical trial validation
- Predictive Insights: Mapping the entire patient treatment path for enhanced understanding
Industry Overview:
The diabetes drug market, segmented by disease type, faces significant growth driven by factors like urban obesity, improved healthcare access, and rising disposable income. Yet, it remains fragmented, leading major players to adopt diverse strategies for market dominance. This case study explores how a diabetes drug manufacturer leveraged patient journey analysis to gain a comprehensive understanding of real-world drug effectiveness.
Pharma Patient Journey Challenge:
The client, a prominent US-based diabetes drug manufacturer, sought a 360° understanding of patient journeys, specifically for diabetes diagnoses. The goal was to bridge the gap between drug performance in ideal settings and real-world scenarios. Additionally, the client aimed to validate clinical trials by assessing ailment progression in patients undergoing various therapies.
Solution Benefits and Business Impact:
Quantzig's patient journey analysis solution empowered the client in several ways:
- Insights into real-world drug performance
- Creation of a validation framework for clinical trial effectiveness
- Enhanced understanding of patient journeys for strategic decision-making
Patient Journey Analysis Predictive Insights:
Patient journey analysis, as provided by Quantzig, enables healthcare firms to map the entire treatment path. Leveraging data from various sources, including hospital records, demographics, laboratory results, progress notes, pharmacy information, and discharge summaries, offers a holistic view of patient experiences.
Challenges in the Diabetes Drug Market:
While the market shows rapid growth, diabetes drug manufacturers face critical challenges:
Innovations: Intense competition necessitates staying abreast of the latest developments, making innovation crucial. Developing diabetes drugs is both expensive and time-consuming, demanding significant investments.
Regulatory Concerns: Compliance with global regulatory guidelines is paramount. Fluctuating changes in requirements highlight the need for manufacturers to stay updated and ensure adherence to mandates.
This case study exemplifies how patient journey analysis can be a game-changer, providing valuable insights into real-world drug effectiveness and clinical trial validation for diabetes drug manufacturers.
Sign in to leave a comment.